NO20090609L - Stabilt preparat omfattende en kombinasjon av et fuktighetsfolsomt legemiddel og et andre legemiddel, samt fremgangsmate for dets fremstilling - Google Patents
Stabilt preparat omfattende en kombinasjon av et fuktighetsfolsomt legemiddel og et andre legemiddel, samt fremgangsmate for dets fremstillingInfo
- Publication number
- NO20090609L NO20090609L NO20090609A NO20090609A NO20090609L NO 20090609 L NO20090609 L NO 20090609L NO 20090609 A NO20090609 A NO 20090609A NO 20090609 A NO20090609 A NO 20090609A NO 20090609 L NO20090609 L NO 20090609L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- drug
- moisture sensitive
- combination
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2006/026899 WO2008008057A1 (fr) | 2006-07-10 | 2006-07-10 | Formulation stable comprenant une combinaison d'un médicament sensible à l'humidité et d'un second médicament et procédure de fabrication de celle-ci |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20090609L true NO20090609L (no) | 2009-03-13 |
Family
ID=37907393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20090609A NO20090609L (no) | 2006-07-10 | 2009-02-09 | Stabilt preparat omfattende en kombinasjon av et fuktighetsfolsomt legemiddel og et andre legemiddel, samt fremgangsmate for dets fremstilling |
Country Status (8)
Country | Link |
---|---|
JP (1) | JP2009542806A (fr) |
CN (1) | CN101478983A (fr) |
BR (1) | BRPI0621867A2 (fr) |
CA (1) | CA2659814A1 (fr) |
IL (1) | IL196273A0 (fr) |
MX (1) | MX2009000358A (fr) |
NO (1) | NO20090609L (fr) |
WO (1) | WO2008008057A1 (fr) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA896851B (en) * | 1988-09-14 | 1990-06-27 | Hoffmann La Roche | Use of ace-inhibitors |
US5006344A (en) * | 1989-07-10 | 1991-04-09 | E. R. Squibb & Sons, Inc. | Fosinopril tablet formulations |
DK9200258U4 (da) * | 1992-03-11 | 1993-07-23 | Merck & Co Inc | Farmaceutisk præparat indeholdende enalapril til brug mod hypertension |
WO2003075842A2 (fr) * | 2002-03-08 | 2003-09-18 | Teva Pharmeceuticals Usa, Inc. | Formulations stables d'inhibiteurs de l'enzyme de conversion de l'angiotensine (ace) |
-
2006
- 2006-07-10 CN CNA2006800552443A patent/CN101478983A/zh active Pending
- 2006-07-10 JP JP2009519417A patent/JP2009542806A/ja active Pending
- 2006-07-10 MX MX2009000358A patent/MX2009000358A/es unknown
- 2006-07-10 CA CA002659814A patent/CA2659814A1/fr not_active Abandoned
- 2006-07-10 WO PCT/US2006/026899 patent/WO2008008057A1/fr active Application Filing
- 2006-07-10 BR BRPI0621867-9A patent/BRPI0621867A2/pt not_active IP Right Cessation
-
2008
- 2008-12-30 IL IL196273A patent/IL196273A0/en unknown
-
2009
- 2009-02-09 NO NO20090609A patent/NO20090609L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2659814A1 (fr) | 2008-01-17 |
IL196273A0 (en) | 2011-08-01 |
BRPI0621867A2 (pt) | 2011-12-20 |
WO2008008057A1 (fr) | 2008-01-17 |
MX2009000358A (es) | 2009-01-27 |
CN101478983A (zh) | 2009-07-08 |
JP2009542806A (ja) | 2009-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081942L (no) | Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser | |
MA30725B1 (fr) | Administration d'inhibiteurs de la dipeptidyl peptidase | |
NO20082159L (no) | Triazolopyridinderivater som inhibitorer av lipaser og fosfolipaser | |
EA200970595A1 (ru) | Производные замещенных индазолов, активные в качестве ингибиторов киназ | |
BRPI0507652A (pt) | composições farmacêuticas compreendendo um derivado de benzoidiazepina e um inibidor da proeìna de fusão de rsv | |
EA200700118A1 (ru) | Амидосоединения и их применение в качестве лекарственных средств | |
NO20071711L (no) | Sammensetninger inneholdende piperacillin, tazobactam og en aminokarboksylsyre i et natriumlaktat fortynningsmiddel | |
ECSP067076A (es) | Derivados de pirimidina urea como inhibidores de la quinasa | |
NO20090628L (no) | Pyridizinon derivativater | |
EA200800726A1 (ru) | Введение ингибиторов дипептидилпептидазы | |
UA89220C2 (ru) | Способ лечения вич/спида путем приема без пищи или в условиях голодания твердого фармацевтического дозированного состава ингибитора вич-протеазы | |
BRPI0414581C1 (pt) | composto, composição farmacêutica compreendendo o referido composto e uso do referido composto | |
NO20064584L (no) | Tetrahydropyridoindolderivater | |
EA200700117A1 (ru) | N-замещенные пиперидины и их применение в качестве фармацевтических препаратов | |
ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
BRPI0507654A (pt) | composição farmacêutica compreendendo um derivado de benzodiazepina e um inibidor da proteìna de fusão de rsv | |
NO20084923L (no) | N-(2-thiazolyl)-amid derivater som GSK-3 inhibitorer | |
NO20083836L (no) | N-hydroksyakrylamidforbindelser | |
NO20075111L (no) | Farmasoytisk sammensetning | |
NO20080220L (no) | Formuleringer med hoy medikament belastning og doseringsformer | |
IL188438A (en) | A heterocyclic active drug with five benzoposes, or a pharmaceutically acceptable salt and aster salts product, as well as compounds containing them and their use as @catol - o @ - @ of @ enzyme @ dead G iltransferase @@ comtI | |
WO2007101710A8 (fr) | Utilisation d'inhibiteurs de protéines de la classe des récepteurs éboueurs dans le traitement de maladies infectieuses | |
NO20054216L (no) | Anvendelse av dipyridamol i kombinasjon med acetylsalisylsyre og en angiotensin II antagonist for forhindring av slag | |
WO2008042480A3 (fr) | Inhibiteurs époxyde de cystéine protéases | |
WO2006042478A8 (fr) | Inhibiteurs de petites molecules de la protease principale des coronavirus, leur preparation et utilisation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |